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Abstract 
G protein-coupled receptors (GPCRs) are the largest family of membrane receptors and mediate the 
effects of a multitude of extracellular cues, such as hormones, neurotransmitters, odorants and light. 
Because of their involvement in numerous physiological and pathological processes and their 
accessibility, they are extensively exploited as pharmacological targets. Biochemical and structural 
biology investigations have clarified the molecular basis of GPCR signaling to a high level of detail. In 
spite of this, how GPCRs can efficiently and precisely translate extracellular signals into specific and 
well-orchestrated biological responses in the complexity of a living cell or organism remains 
insufficiently understood. To explain the high efficiency and specificity observed in GPCR signaling, it 
has been suggested that GPCR might signal in discrete nanodomains on the plasma membrane or 
even form stable complexes with G proteins and effectors. However, directly testing these 
hypotheses has proven a major challenge. Recent studies taking advantage of innovative optical 
methods such as fluorescence resonance energy transfer (FRET) and single-molecule microscopy 
have begun to dig into the organization of GPCR signaling in living cells on the spatial (nm) and 
temporal (ms) scales on which cell signaling events are taking place. The results of these studies are 
revealing a complex and highly dynamic picture, whereby GPCRs undergo transient interaction with 
their signaling partners, membrane lipids and the cytoskeleton to form short-lived signaling 
nanodomains both on the plasma membrane and at intracellular sites. Continuous exchanges among 
such nanodomains via later diffusion as well as via membrane trafficking might provide a highly 
sophisticated way of controlling the timing and location of GPCR signaling. Here, we will review the 
most recent advances in our understanding of the organization of GPCR signaling in living cells, with 
a particular focus on its dynamics. 
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1. Introduction 1 
During evolution from simple unicellular to complex multicellular organisms, cells have developed 2 
increasingly sophisticated strategies to sense the extracellular environment and communicate with 3 
each other. The large superfamily of G protein-coupled receptors (GPCRs) arguably represent the 4 
most successful result of this amazing evolutionary endeavor, which enabled our cells to sense and 5 
decode a large number of extracellular cues, encompassing light, odorants, hormones and 6 
neurotransmitters (Pierce et al., 2002; Lefkowitz, 2004). Given their accessibility, diversity and well-7 
defined pharmacology, GPCRs have also served as major drug targets. As a result, at least one third 8 
of all drugs currently on the market target these receptors (Hauser et al., 2017). Moreover, there is 9 
large scope for further development since only a fraction of all potentially targetable GPCRs are 10 
currently exploited for pharmacological purposes. 11 
Given the fundamental biological role and importance of GPCRs as drug targets, all major steps in 12 
GPCR signaling have been intensively investigated. By as early as the late 70’s, pioneering work on 13 
the mechanisms of hormone action initiated by Earl Sutherland and Ted Rall in the late 50’s and later 14 
taken over by Alfred G. Gilman and Martin Rodbell had already clarified that hormones like 15 
adrenaline and glucagon act via binding to a specific receptor located on the plasma membrane, 16 
triggering the activation of G proteins in a process that requires GTP, ultimately leading to the 17 
production of cyclic AMP (cAMP) by adenylyl cyclase – for a historical perspective see (Beavo and 18 
Brunton, 2002). In 1986, the sequence of the β2-adrenergic receptor was elucidated by the group of 19 
Robert Lefkowitz, revealing an unexpected similarity with rhodopsin (Dixon et al., 1986). More 20 
recently, there has been enormous progress in the clarification of the structural basis of GPCR 21 
signaling, with the successful elucidation of the three dimensional structures of several GPCRs in 22 
different conformational states (Cherezov et al., 2007; Rasmussen et al., 2007) as well as in complex 23 
with both G proteins (Rasmussen et al., 2011; Koehl et al., 2018; Liang et al., 2017; Zhang et al., 24 
2017) and arrestins (Kang et al., 2015; Zhou et al., 2017). 25 
Despite these tremendous advances, we are just beginning to understand how GPCRs function and 26 
are regulated within the complexity of an intact cell or organism to produce specific effects. Indeed, 27 
recent data, mainly obtained with innovative microscopy approaches, indicate that GPCRs are far 28 
more complex and dynamic than previously thought, being able to signal at distinct signaling 29 
nanodomains both at the cell surface and on intracellular membranes. Understanding this 30 
complexity is going to be crucial to answer fundamental and still unresolved questions such as how 31 
GPCRs can produce specific effects and might pave the way to innovative pharmacological 32 
approaches. 33 
 34 
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2. Early evidence for signal compartmentalization 35 
Whereas the highly successful model of GPCR signaling derived from the early biochemical studies 36 
described well the general mechanisms of GPCR signaling, it soon emerged that such a model was 37 
insufficient to fully explain the effects observed in intact cells and tissues – for a comprehensive 38 
review see (Beavo and Brunton, 2002; Steinberg and Brunton, 2001). For example, already in early 39 
studies in perfused hearts it was noted that whereas both epinephrine and prostaglandin E1 induce 40 
similar increases of cAMP and activate protein kinase A (PKA), only stimulation of adrenergic 41 
receptors with epinephrine was able to significantly activate glycogen phosphorylase, increase heart 42 
contractility and induce troponin I phosphorylation (Keely, 1979; Brunton et al., 1979). Subsequently 43 
it was found that the β-adrenergic agonist isoproterenol but not PGE1 increases the amount of 44 
cAMP and PKA activity in the particulate fraction of rabbit heart lysates, which mainly contain type-II 45 
isoforms of PKA (Hayes et al., 1980). These and similar findings obtained in isolated cardiomyocytes 46 
led Buxton and Brunton to hypothesize that β-adrenergic and PGE1 receptors might induce cAMP 47 
accumulation and PKA activation in distinct subcellular microdomains, leading to different biological 48 
effects (Buxton and Brunton, 1983). 49 
In parallel, experiments suggested that adenylyl cyclases and other signaling proteins might not be 50 
randomly distributed on biological membranes. For instance, pioneering work by Tolkovsky and 51 
Levitzki provided indirect evidence that on turkey erythrocyte membranes adenosine receptors 52 
might be pre-coupled to adenylyl cyclases (note that the role of G proteins was not known at that 53 
time), whereas β-adrenergic receptors would activate adenylyl cyclases by random collision 54 
(Tolkovsky and Levitzki, 1978; Tolkovsky and Levitzki, 1978). 55 
Several early studies concentrated on the role of lipid domains on the plasma membrane. These 56 
studies suggested that GPCR signaling might preferentially occur in lipid rafts and caveolae (Insel et 57 
al., 2005). Lipid rafts were initially identified biochemically as small (micrometer-sized) sphingolipid- 58 
and cholesterol-rich membrane domains that are resistant to detergent extraction at low 59 
temperature (Simons and Ikonen, 1997). A fraction of these domains contains also caveolins and, 60 
morphologically, corresponds to small invaginations of the plasma membrane, known as caveolae, 61 
which can be visualized by electron microscopy (Simons and Toomre, 2000). Based on biochemical 62 
evidence, several groups proposed that receptors, G proteins and adenylyl cyclases preferentially 63 
accumulate within lipid rafts and caveolae, suggesting a possible functional role for the resulting 64 
inhomogeneous distribution of GPCRs and their signaling partners on the plasma membrane (Insel et 65 
al., 2005). For instance, it has been proposed that, in cardiomyocytes, β2-adrenergic receptors are 66 
preferentially localized in caveolae and T-tubules, which have a membrane composition similar to 67 
caveolae, whereas β1-adrenergic receptors would be mainly excluded from these structures (Xiang 68 
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et al., 2002; Nikolaev et al., 2010). This has been suggested to play an important role in determining 69 
the specificity of signaling downstream of β1- vs. β2-adrenergic receptors, which have distinct 70 
biological effects on cardiomyocytes. In particular, the spatial proximity of β2-adrenergic receptors, 71 
Gs proteins and adenylyl cyclases in caveolae has been suggested to be required for β2-adrenergic 72 
receptors to produce physiological responses (Xiang et al., 2002; MacDougall et al., 2012; Wright et 73 
al., 2014).  74 
 75 
3. New imaging approaches to address an old problem 76 
Although the concept of signal compartmentalization is now widely accepted and supported by 77 
growing evidence, there has initially been considerable resistance to accept a non-random 78 
distribution of signaling molecules, possibly due to the popularity of the Singer and Nicolson’s fluid 79 
mosaic model of the plasma membrane (Singer and Nicolson, 1972). Moreover, directly 80 
demonstrating the existence of signaling domains in living cells has proven challenging. A major 81 
problem was the lack of adequate tools to localize signaling events in living cells, as the classical 82 
biochemical and pharmacological methods typically used in these studies require cell disruption and 83 
have no spatial and very low temporal resolution. These limitations have been at least partially 84 
overcome by the introduction of innovative microscopy methods that allow scientists to directly 85 
visualize receptor signaling in living cells. A first major advance was represented by the introduction 86 
of reporters based on fluorescence resonance energy transfer (FRET) (Milligan and Bouvier, 2005; 87 
Lohse et al., 2012; Lefkimmiatis and Zaccolo, 2014; Calebiro and Maiellaro, 2014). These methods 88 
were crucial to provide direct evidence for the existence of signaling domains on the plasma 89 
membrane as well as inside cells (Calebiro et al., 2010; Irannejad et al., 2013; Irannejad et al., 2017; 90 
Godbole et al., 2017; Surdo et al., 2017; Castro et al., 2010; Maiellaro et al., 2016). Among other 91 
findings, this revealed that despite cAMP being a small water-soluble molecule, cAMP and PKA 92 
signals can be highly confined on the plasma membrane as well as at other intracellular 93 
compartments (Surdo et al., 2017; Castro et al., 2010; Maiellaro et al., 2016). This organization is 94 
likely particularly relevant in highly specialized cells such as cardiomyocytes and neurons, where 95 
neurotransmitter and hormone signals have to be rapidly converted into coordinated cellular 96 
responses such as synaptic plasticity or heart contraction. 97 
More recently, the rapid development of innovative methods based on single-molecule microscopy 98 
has allowed probing the organization and dynamics of GPCR signaling nanodomains with 99 
unprecedented spatiotemporal resolution – for a detailed review see (Calebiro and Sungkaworn, 100 
2017)). These methods hold great promise to directly study the dynamic organization of GPCR 101 
signaling on the spatial and temporal scales where GPCR signaling events are taking place. 102 
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 103 
4. The importance of the cytoskeleton 104 
The cytoskeleton that is closely associated with the plasma membrane is often termed membrane 105 
skeleton. It consists of actin filaments, microtubules, and associated proteins. The membrane 106 
skeleton is somewhat different from the bulk cytoskeleton: it interacts with the plasma membrane 107 
and proteins that are located at the plasma membrane, playing a role in numerous cellular functions, 108 
such as endocytosis and exocytosis. Moreover, it provides anchors for the localization of 109 
transmembrane proteins. The membrane skeleton covers almost the entire cytoplasmic surface of 110 
the plasma membrane, and is intimately associated with clathrin-coated pits and caveolae (Morone 111 
et al., 2006). Based on results of early single-particle tracking (SPT) experiments with gold 112 
nanoparticles (Sako and Kusumi, 1994) and optical tweezers (Edidin et al., 1991; Sako and Kusumi, 113 
1995), it was proposed that the membrane skeleton partitions the plasma membrane, influencing 114 
the diffusion of membrane-associated molecules (Jacobson et al., 1995; Kusumi et al., 2005). These 115 
and later measurements with fluorescently labelled proteins indicated that membrane molecules 116 
are temporarily confined into membrane compartments of 40–300 nm, consistent with the size of 117 
the membrane skeleton mesh (Murase et al., 2004). By observing membrane proteins and lipids 118 
embedded in the plasma membrane, it was found that they both undergo so called ‘hop’ diffusion, 119 
characterized by alternating phases of free diffusion and transient confinement (Suzuki et al., 2005; 120 
Fujiwara et al., 2002; Hiramoto-Yamaki et al., 2014). ‘Hop’ diffusion has been demonstrated for 121 
different types of membrane receptors, including GPCRs, which were investigated in a pioneering 122 
single-particle tracking study by the group of Akihiro Kusumi (Suzuki et al., 2005). In this study, 123 
tracking of µ-opiod receptors labelled with gold nanoparticles at the impressive temporal resolution 124 
of 25 µs revealed that these receptors jump between adjacent membrane compartments, in which 125 
they are temporally trapped. These findings led to the formulation of the ‘fence-and-picket’ model 126 
of the plasma membrane. According to this model, the membrane skeleton (‘fences’) and integral 127 
membrane proteins associated with it (‘pickets’) provide physical barriers to the diffusion of both 128 
membrane proteins and lipids, leading to compartmentalization of the plasma membrane in small 129 
nanodomains (Fujiwara et al., 2002; Kusumi et al., 2011). Importantly, the confinement of 130 
interacting molecules in such nanodomains has been suggested to increase the probability of their 131 
encounters, thus potentially increasing the rate of biochemical reactions (Saxton, 2002). 132 
The cytoskeleton does not only provide barriers to receptor diffusion, but also provides anchor 133 
points for receptors and other membrane proteins, further contributing to the formation of signaling 134 
nanodomains and controlling their spatial arrangement on the plasma membrane. This has been 135 
probably best studied for ionotropic receptors at chemical synapses. It has been shown that 136 
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ionotropic glutamate receptors are constantly diffusing within the plasma membrane, which 137 
promotes the exchange of receptors between synaptic and extrasynaptic sites (Triller and Choquet, 138 
2003). However, the local entrapment of receptors at postsynaptic densities is essential for synaptic 139 
function. This is achieved via a network of molecular interactions with the membrane skeleton and 140 
associated transmembrane proteins (Sheng and Sala, 2001; Garner et al., 2000). For instance, single-141 
particle tracking in living cells and super-resolution imaging in fixed cells have revealed that the 142 
nanoscale localization and lateral mobility of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 143 
(AMPA) receptors can greatly influence synaptic transmission (Compans et al., 2016). In the case of 144 
AMPA receptors, the interactions with the cytoskeleton have been shown to be mediated by 145 
stargazin (also known as TARP γ2), an auxiliary subunit of the AMPA receptor, which, in turn, 146 
interacts with the postsynaptic density protein 95 (PSD95). PSD95 is a scaffold that plays a crucial 147 
role in the organization of post-synaptic densities. This involves interactions with the actin 148 
cytoskeleton mediated by binding of PDS95 to α-actinin (Matt et al., 2018). Since the interactions 149 
between AMPA receptor and stargazin are transient, this allows a dynamic exchange of AMPA 150 
receptors between synaptic and extrasynaptic sites (Bats et al., 2007). Moreover, it has been shown 151 
that glutamate stimulation decreases the stargazin-mediated immobilization of AMPA receptors at 152 
post-synaptic sites, allowing a faster replacement of desensitized receptors with new ones. Thus, 153 
this might provide a mechanism to fine tune synaptic sensitivity to repeated stimulation. 154 
Although the mechanisms responsible for the organization of GPCRs on the plasma membrane are 155 
less understood than in the case of ionotropic receptors, there is evidence that also GPCRs might 156 
interact with the actin cytoskeleton. For example, single-molecule experiments in simple cell models 157 
have shown that GABAB receptors undergo dynamic interactions with the actin cytoskeleton, likely 158 
mediated by an as yet unknown scaffold, causing their preferential arrangement along actin fibers 159 
(Calebiro et al., 2013). As in the case of AMPA receptors, agonist stimulation with GABA was also 160 
found to weaken the interaction of GABAB receptors with the cytoskeleton, leading to an increase of 161 
their lateral mobility. Whereas the occurrence and functional relevance of this organization in 162 
neurons is presently unknown, it is tempting to speculate that it might be involved in controlling the 163 
precise localization and/or function of GABAB receptors at synapses (Calebiro et al., 2013). Another 164 
receptor that has been recently investigated in this respect is the somatostatin receptor type 2 165 
(SSTR2), which had been shown to interact with the acting-binding scaffold filamin A (Peverelli et al., 166 
2014). Recent single-molecule data by our group indicate that SSTR2 undergoes transient 167 
interactions with filamin A, which lead to a preferential localization of SSTR2 along actin fibers and 168 
participate in restraining SSTR2 diffusion on the plasma membrane. These interactions are increased 169 
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by agonist stimulation and are apparently required for efficient SSTR2 recruitment to clathrin-coated 170 
pits and internalization in response to agonist stimulation (Treppiedi et al., 2018). 171 
 172 
5. Hot-spots for GPCR signaling on the plasma membrane 173 
As mentioned above, despite several lines of evidence suggesting the possible existence of GPCR 174 
signaling nanodomains on the plasma membrane, their demonstration has proven extremely 175 
challenging. In fact, it has been only recently, with the further development of methods based on 176 
single-molecule and super-resolution microscopy that their direct visualization has become possible. 177 
These methods are not only able to resolve the organization of receptors and their signaling partners 178 
but can also localize downstream signaling events. For instance, in a recent elegant study, Mo et al. 179 
developed a new type of sensors – based on changes in the fluorescence fluctuation of the 180 
fluorescent protein TagRFP-T when in close proximity to another fluorescent protein called Dronpa – 181 
that allowed them to resolve PKA activity on the plasma membrane of living cells with a resolution 182 
up to three times better than the diffraction limit (Mo et al., 2017). This revealed the existence of 183 
PKA signaling nanodomains, which likely result from PKA clustering at the plasma membrane 184 
mediated via interaction with PKA anchoring proteins such as AKAP79. 185 
More recently, our group succeeded for the first time in directly visualizing individual receptors and 186 
G proteins as they diffuse, interact and signal on the surface of intact cells (Sungkaworn et al., 2017). 187 
This study – which focused on α2A-adrenergic receptor/Gi and β2-adrenergic receptors/Gs as model 188 
receptor/G protein pairs – has led to a number of important observations. Notably, we could directly 189 
measure the duration of receptor–G protein interactions in intact cells, showing that they are 190 
transient and last approximately 1-2 seconds. Whereas we observed the occurrence of transient 191 
receptor–G protein interactions also in the absence of ligands, which were linked to the basal 192 
constitutive activity of the receptors, we did not observe preformed, stable receptor–G protein 193 
complexes, as proposed by some previous studies. However, differences might exist in the degree 194 
and stability of pre-association among different receptors and/or G proteins. For instance, using 195 
bioluminescence resonance energy transfer (BRET) and time-resolved fluorescence resonance 196 
energy transfer (FRET), the protease-activated receptor 1 (PAR1) was found in a previous study to 197 
pre-associate with Gi but not with G12 (Ayoub et al., 2010). Second, we found that agonists mainly act 198 
by increasing the association rate (kon) between receptors and G proteins, as expected in the case of 199 
protein interactions that proceed through major conformational changes. Third, we discovered that 200 
receptor−G protein interactions and G protein activation do not occur randomly on the plasma 201 
membrane, but rather at dynamic nanodomains that we termed ‘hot spots’ (see Figure 1). Based on 202 
our recent results and simulations, we hypothesize that, by increasing the local effective 203 
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concentration of receptors and G proteins, these hot spots increase the speed and efficiency of their 204 
interactions, while allowing GPCR signals to occur locally. These data help to clarify one of the most 205 
fundamental and debated aspect of GPCR signaling, i.e. whether receptors are pre-coupled to G 206 
proteins or interact with them via random collisions. At least in principle, stable receptor complexes 207 
could permit fast and local signaling, but at the expense of signal amplification. In contrast, pure 208 
random coupling would favor signal amplification but would also bring low speed and efficiency. By 209 
establishing a sort of ‘dynamic pre-coupling’ – i.e. via allowing transient receptor–G protein 210 
interactions in the basal state, and keeping the involved receptors and G proteins near to each other 211 
thanks to the barriers provided by the cytoskeleton – nature seems to have found the ideal balance 212 
between signal amplification and speed. These and similar mechanisms might play a crucial role in 213 
determining the high efficiency and specificity observed among GPCRs and might provide a means of 214 
controlling GPCR signaling in space and time. 215 
 216 
 217 
Figure 1. ‘Hot spots’ for GPCR signaling on the plasma membrane. Dynamic interactions between receptors, G 218 
proteins and barriers provided by the cytoskeleton lead to the formation of dynamic nanodomains on the 219 
plasma membrane that increase the efficiency of G protein activation, while allowing GPCRs to induce local 220 
signals.  221 
 222 
6. Lipid nanodomains revisited 223 
In spite of the biochemical evidence supporting the existence of lipid rafts, the size, dynamics and 224 
even existence of lipid domains on the plasma membrane has proven hard to demonstrate in living 225 
cells. This has sparkled an intense debate on the exact nature, role and functional relevance of lipid 226 
rafts (Munro, 2003; Eggeling et al., 2009; Eggeling, 2015). Traditionally, it was assumed that lipid 227 
rafts are rather stable plasma membrane compartments containing sphingolipids, cholesterol and a 228 
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unique set of resident (mainly GPI-anchored) proteins which float as ‘rafts’ on the plasma membrane 229 
and might provide specialized platforms for receptor signaling (Simons and Ikonen, 1997). This idea 230 
was mainly based on the fact that rafts could be isolated as detergent-resistant lipid patches and the 231 
observation of phase separation in model membranes (Eggeling, 2015). However, the most recent 232 
imaging studies that attempted to directly visualize lipid rafts in living cells failed to detect stable 233 
lipid domains on the plasma membrane (Eggeling et al., 2009). 234 
Early attempts to directly visualize the spatial arrangement of fluorescently labelled GPI-anchored 235 
proteins by fluorescence microscopy in living cells showed fairly homogenous membrane staining, 236 
suggesting that either lipid rafts did not exist in vivo or were smaller than the lateral resolution of 237 
conventional fluorescence microscopy, which is about 200 nm (Mayor and Maxfield, 1995). The 238 
latter hypothesis was supported by FRET measurements suggesting that GPI-anchored proteins may 239 
associate in clusters smaller than 70 nm (Varma and Mayor, 1998). A subsequent study by the same 240 
group further narrowed down the estimated size of such clusters to less than 5 nm and a maximum 241 
of 4 GPI-anchored proteins per cluster (Sharma et al., 2004). 242 
As a complementary approach, several groups have measured the diffusion of fluorescently labelled 243 
lipids and GPI-anchored proteins by either single-particle tracking or fluorescence correlation 244 
spectroscopy (FCS) in an attempt to understand their spatiotemporal organization at the plasma 245 
membrane. The results have shown that both GPI-anchored proteins and lipids undergo transient 246 
confinement in small nanodomains on the plasma membrane (Fujiwara et al., 2002; Lenne et al., 247 
2006). However, multiple factors could contribute to such behavior, complicating the interpretation 248 
of the results. A first important factor is the cytoskeleton, which, as mentioned above, has been 249 
shown to provide barriers to both protein and lipid diffusion in the plasma membrane. However, 250 
there is some evidence that the confinement of membrane lipids and GPI-anchored proteins is not 251 
always dependent on the presence of an intact cytoskeleton and could be altered by manipulating 252 
the lipid composition of the plasma membrane, supporting a role for lipid–protein interactions in the 253 
transient confinement of GPI-anchored proteins (Lenne et al., 2006). 254 
To more precisely measure the residency time of fluorescent lipids in membrane nanodomains, the 255 
groups of Stefan Hell and Christian Eggeling have developed novel approaches based on stimulated 256 
emission depletion (STED) microscopy, which enable them to control and narrow down the size of 257 
the excited volume in FCS measurements (Eggeling et al., 2009; Honigmann et al., 2014). This 258 
allowed them to investigate the diffusion of membrane molecules on different spatial scales. 259 
Overall, their results indicate that sphingolipids exhibit transient arrests as they diffuse on the 260 
plasma membrane, which are most likely caused by transient interactions with immobile or slow-261 
diffusing membrane proteins. These trapping events last for approximately 10 ms and occur in areas 262 
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that are smaller than the resolution of the employed method, which is about 20 nm. These 263 
interaction sites are stable over a few seconds, during which they do not seem to diffuse within the 264 
plasma membrane. This behavior seems to be specific for sphingolipids, and to a much lesser extent 265 
phosphoethanolamine, with no correlation with the preference of the investigated lipid analogs for 266 
liquid-ordered membrane environments. Whereas these observations further support the 267 
occurrence of short-lived lipid–protein complexes, they seem to rule out the classical model of lipid 268 
rafts as stable and ordered lipid patches floating within the plasma membrane. 269 
Another point to consider is that whereas lipid phase separation might affect protein dynamics on 270 
the plasma membrane, protein–protein interactions, such as those leading to clustering of GPI-271 
anchored proteins during their activation, might also favor the formation of larger and possibly more 272 
stable lipid–protein complexes or nanodomains (Kusumi et al., 2012). 273 
Overall, these recent data point to a much more dynamic picture than previously imagined, whereby 274 
membrane proteins and lipids undergo transient interactions that might still be relevant for the 275 
spatiotemporal organization of receptor signaling, but which do not necessarily lead to the 276 
formation of stable lipid–protein domains.  277 
 278 
7. GPCR signaling at intracellular domains 279 
Whereas signaling by GPCRs has long been thought to be restricted to the plasma membrane, a 280 
growing body of evidence indicates that GPCRs can also signal on intracellular membranes. The use 281 
of advanced optical methods such as FRET and conformation-sensitive biosensors was not only 282 
instrumental for these recent discoveries but also allowed scientists to identify the intracellular 283 
compartments where GPCR signaling is taking place. A first study by our group on endogenous 284 
thyroid stimulating hormone (TSH) receptors in thyroid cells revealed that these prototypical GPCRs 285 
for glycoprotein hormones remain active after internalization, leading to persistent cAMP signaling 286 
(Calebiro et al., 2009). Similar results were obtained by the group of Jean-Pierre Vilardaga studying 287 
the parathyroid hormone (PTH) receptor (Ferrandon et al., 2009). These early studies provided the 288 
first demonstration that GPCRs can continue signaling via cAMP at intracellular sites after 289 
internalization. Moreover, they suggested that TSH and PTH receptors were probably signaling in 290 
distinct compartments, i.e. a perinuclear compartment associated with the Golgi complex and early 291 
endosomes, respectively. However, it was only with the introduction of biosensors based on 292 
conformation-sensitive nanobodies that it was possible to directly visualize the subcellular sites of 293 
receptor and G protein activation in living cells. Using this elegant approach, the group of Mark von 294 
Zastrow was able to show that β2-adrenergic receptors remain active in early endosomes, where 295 
they induce local Gs protein activation (Irannejad et al., 2013). More recently, our group further 296 
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investigated the nature and dynamics of the intracellular compartment where TSH receptors are 297 
signaling. For this purpose, we used a combination of FRET sensors measuring cAMP levels and PKA 298 
activity, which we tethered to different subcellular compartments, together with the previously 299 
developed conformation-sensitive biosensor for Gs protein activation (Godbole et al., 2017). The 300 
results of this study demonstrated that upon TSH stimulation, the TSH receptor and its ligand traffic 301 
retrogradely to the trans-Golgi network, where they induce local Gs protein activation, cAMP 302 
production and PKA activation. Importantly, this leads to a delayed phase of cAMP/PKA signaling at 303 
the Golgi/trans-Golgi network, which is required for TSH to efficiently induce phosphorylation of the 304 
cAMP response element-binding protein (CREB) and transcription of early genes (Godbole et al., 305 
2017). Interestingly, signaling within the Golgi complex has also been recently demonstrated for the 306 
β1-adrenergic receptor, even though in this case it has been proposed that it is the ligand (adrenalin) 307 
to reach the receptors, which are already located on membranes of the Golgi complex, via facilitated 308 
transport across cellular membranes (Irannejad et al., 2017). In the meantime, studies form several 309 
groups have demonstrated signaling at intracellular sites for a number of receptors (Kotowski et al., 310 
2011; Feinstein et al., 2013; Kuna et al., 2013; Merriam et al., 2013; Ismail et al., 2016; Lyga et al., 311 
2016), suggesting that this might be a rather common feature among GPCRs. Moreover, there is 312 
some evidence that GPCRs might also signal on the nuclear envelope (Tadevosyan et al., 2012) as 313 
well as in mitochondria (Hebert-Chatelain et al., 2016; Suofu et al., 2017). 314 
These novel and exciting findings point to a previously unsuspected level of complexity in GPCR 315 
signaling. The fact that individual GPCRs can induce local signals in distinct subcellular compartments 316 
likely plays a major role in determining their biological effects. This provides a new basis to explain 317 
the high diversity found within the GPCR superfamily, in spite of the fact that all these receptors 318 
converge on just a few common signaling pathways. At the same time, they reveal an extremely 319 
dynamic picture. Indeed, data on both TSH (Godbole et al., 2017) and β2-adrenergic receptors 320 
(Irannejad et al., 2013) indicate that GPCR signaling is highly controlled in space and time during 321 
receptor internalization and intracellular trafficking, apparently occurring in short ‘bursts’ once 322 
receptors enter well-defined membrane sub-domains of early endosomes or the trans-Golgi 323 
network. This high degree of integration between intracellular trafficking and signaling likely 324 
provides a key mechanism to fine tune GPCR signaling, which, once understood in its complexity, 325 
might also offer novel opportunities to modulate GPCRs for therapeutic purposes. 326 
 327 
8. Concluding remarks 328 
Altogether, the new findings obtained with advanced optical methods in living cells are deeply 329 
changing our views on the spatiotemporal organization of GPCR signaling cascades. Above all, they 330 
12 
 
have revealed a highly complex and dynamic picture, whereby GPCRs can rapidly form transient 331 
signaling nanodomains on the plasma membrane as well as at intracellular sites (Figure 2). We are 332 
only beginning to characterize these nanodomains, investigate which factors lead to their formation 333 
and understand their impact on GPCR signaling. As it is often the case, the development of 334 
innovative methods with increased power and resolution, has been instrumental for these 335 
discoveries. The current rapid progress in the fields of single-molecule and super-resolution 336 
microscopy combined with a growing awareness of the need for large multidisciplinary efforts to 337 
tackle biological complexity is likely to offer novel, exciting opportunities in the near future to 338 
further investigate the mechanisms and relevance of the spatiotemporal dynamics found in GPCR 339 
signaling. 340 
 341 
Figure 2.  Dynamic nanodomains for GPCR signaling. Recent studies have revealed a highly complex and 342 
dynamic picture, whereby GPCRs can signal at dynamic nanodomains located both on the plasma membrane 343 
and on membranes of intracellular compartments such as early endosomes, the trans-Golgi network or the 344 
Golgi complex. Dynamic interactions of receptors and other signaling proteins with membrane lipids, the 345 
cytoskeleton and protein scaffolds likely play important role in the formation of these nanodomains. Lateral 346 
diffusion and trafficking control the localization of GPCRs within the nanodomains, which might provide a 347 
means to modulate the timing and location of GPCR signaling. 348 
 349 
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